Feasibility of combined therapy: percutaneous left atrial appendage closure and transcatheter edge-to-edge repair
Cardiovascular Intervention and Therapeutics · 2025
DOI: 10.1007/s12928-024-01065-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Intervention and Therapeutics, 2025. Verfasst von Nobuyuki Fukuda und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Second Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan. Hauptthemen laut MEDLINE: Atrial Appendage, Atrial Fibrillation, Cardiac Catheterization, Mitral Valve Insufficiency. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Patients with atrial fibrillation (AF) often present with concomitant significant mitral regurgitation (MR). Percutaneous left atrial appendage closure (LAAC) is indicated for patients with AF to prevent thromboembolism and reduce the need for long-term anticoagulation. Transcatheter edge-to-edge repair (TEER) is recommended for patients with significant MR. However, the feasibility and efficacy of combining these therapeutic interventions remain uncertain. This study included consecutive patients who underwent LAAC. Feasibility was assessed by comparing outcomes between those undergoing combined LAAC + TEER and those receiving LAAC alone. Among 192 patients, 11 underwent the combined LAAC + TEER procedure, while 181 underwent LAAC alone. Procedural success was high in both groups (100% vs. 99%). At the 1-year follow-up, the incidence of significant device leak and device-related thrombus did not differ significantly between the groups (0% vs. 1.1% and 0% vs. 6.7%, respectively; p > 0.05 for both). Additionally, the cumulative incidence of thromboembolic and bleeding events was comparable between the two groups (thromboembolic p = 0.57 and bleeding p = 0.42). The combination of LAAC + TEER may be a feasible and effective therapeutic strategy when performed in carefully selected patients at high-volume, experienced centers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Second Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
- The Second Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan. teimamu@med.u-toyama.ac.jp.
Zitieren
APA
Fukuda, N., Imamura, T., Tanaka, S., Kataoka, N., Ushijima, R., Ueno, H., & Kinugawa, K. (2025). Feasibility of combined therapy: percutaneous left atrial appendage closure and transcatheter edge-to-edge repair. Cardiovascular Intervention and Therapeutics. https://doi.org/10.1007/s12928-024-01065-7
Vancouver
Fukuda N, Imamura T, Tanaka S, Kataoka N, Ushijima R, Ueno H, et al. Feasibility of combined therapy: percutaneous left atrial appendage closure and transcatheter edge-to-edge repair. Cardiovascular Intervention and Therapeutics. 2025. doi:10.1007/s12928-024-01065-7
BibTeX
@article{Fukuda2025,
author = {Fukuda, Nobuyuki and Imamura, Teruhiko and Tanaka, Shuhei and Kataoka, Naoya and Ushijima, Ryuichi and Ueno, Hiroshi and Kinugawa, Koichiro},
title = {Feasibility of combined therapy: percutaneous left atrial appendage closure and transcatheter edge-to-edge repair},
journal = {Cardiovascular Intervention and Therapeutics},
year = {2025},
doi = {10.1007/s12928-024-01065-7}
}
EUVIMED